President Trump signed an executive order Thursday targeting imported brand name drugs with a 100 percent tariff, citing the U.S.’s “import reliance” as reason for the decision. “I have determined that it is necessary and appropriate to impose a 100 percent ad valorem duty rate on the import of patented pharmaceuticals and associated pharmaceutical ingredients,”…
